Skip to main content
Clinical Trials/NCT06295900
NCT06295900
Recruiting
Not Applicable

The Effect of Aromatherapy Massage Applied to Intensive Care Patients on Sleep Quality

Nilgün Erdoğan1 site in 1 country62 target enrollmentJanuary 5, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Nilgün Erdoğan
Enrollment
62
Locations
1
Primary Endpoint
Patient Introduction Form
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Sleep disturbance is one of the most common complaints of patients admitted to ICU. Insufficient sleep in intensive care units may be associated with environmental reasons such as excessive light at night, loud warning sounds and mechanical ventilation alarms, as well as non-environmental factors, including the situation at the time of admission. Sleep assessment is subjective in nature, so it is difficult to perform in the ICU. Since communication with the patient is prevented, clear information about perceived rest and disturbing factors cannot be provided. For this reason, night rest is an issue that is often forgotten and ignored. This study applied a mixture of lavender, medicinal chamomile and neroli oil (in 20 ml of sweet almond oil; lavender oil 2 drops, medicinal chamomile 4 drops, neroli oil 6 drops) to patients who were monitored in intensive care on high-flow and oxygen, once a day for three days. This study will be conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on sleep quality.

Registry
clinicaltrials.gov
Start Date
January 5, 2024
End Date
December 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Nilgün Erdoğan
Responsible Party
Sponsor Investigator
Principal Investigator

Nilgün Erdoğan

Principal Investigator

Nigde Omer Halisdemir University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and over,
  • Conscious patients,
  • Staying in intensive care for 24 hours or more,
  • Those with stable hemodynamic status,
  • Receiving O2 therapy,
  • Intubated patients, patients who have passed 24 hours after being extubated,
  • Those whose saturation level is 85 and above

Exclusion Criteria

  • Patients with peripheral neuropathy or quadriplegia,
  • Patients with open wounds on their body,
  • Patients receiving analgesia and sedation infusion,
  • Patients who are sedated,
  • Patients in delirium,
  • Patients with allergies detected before starting the application

Outcomes

Primary Outcomes

Patient Introduction Form

Time Frame: 1 year

In the "Patient Introduction Form" prepared by the researcher based on the literature in order to obtain information about the characteristics of the patients who will constitute the sample, the patients' medical diagnosis, age, gender, chronic diseases, length of stay in intensive care, use of analgesic, sedative and hypnotic drugs used, normal sleep hours at night were included. There are questions about (sleep duration, daytime sleep, sleep hours, sleep aids used, etc.).

Secondary Outcomes

  • Patient Follow-up Form(1 year)

Study Sites (1)

Loading locations...

Similar Trials